Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)
AIDS Malignancy Consortium
Antiva Biosciences
Antiva Biosciences